SB Pre Gene PGTA & NIPT
Accurate and safe screening of fetal genetic conditions using maternal blood.
Highlights:
Prenatal screening has been revolutionised over the last ten years with the emergence of non-invasive prenatal testing (NIPT) enabling vast improvements in accuracy and precision through the detection of circulating fetal DNA (cfDNA) in maternal blood. Non-invasive prenatal testing has been so successful since its introduction that it has since been called the vanguard of genomic medicine. NIPT is a screening test, and all high-risk results must be followed up with a confirmatory invasive test.
Our SBL NIPT tests reduce the risk of false positives occurring, giving clinicians the confidence to refer mothers for an invasive test only when there is a high risk that the fetus is affected. This means fewer pregnant women will undergo unnecessary invasive follow-up procedures such as an amniocentesis or chorionic villus sampling (CVS) which can be stressful, painful and may carry a small risk of miscarriage.